The potential of theragnostic 124I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma
N. Luther(Memorial Sloan Kettering Cancer Center), Mark M. Souweidane(Memorial Sloan Kettering Cancer Center), Mark Edgar(Mayo Clinic in Arizona), Zhiping Zhou(Second Affiliated Hospital of Fujian Medical University), N K Cheung(Memorial Sloan Kettering Cancer Center), Pat Zanzonico(Memorial Sloan Kettering Cancer Center), John L. Humm(Memorial Sloan Kettering Cancer Center)
Cited by 49
Related Papers
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
|The Lancet|2010|1.1k
Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
|New England Journal of Medicine|2013|825
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|659
Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.
|Journal of Clinical Oncology|1987|417
A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels–Alder Click Chemistry
|Journal of Nuclear Medicine|2013|301